U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796959) titled 'Combined [18F]-FDG PET-MRI in Diagnostics and Surveillance of Small Bowel Crohn's Disease' on Jan. 21.
Brief Summary: Patients with suspected small bowel Crohn's disease (CD) are assessed with PET-MRE using 18-fluorodeoxyglucose ([18F]-FDG) tracer. Patients are recruited from the outpatient clinic of gastroenterology in Turku University Hospital. The patients must fulfil the eligibility criteria and give their signed approvement prior to their enrolment into the study. This is an observational single-center imaging study.
35 patients with high clinical suspicion of active small bowel CD will be enrolled to study. After the diagnost...